Observational study of treatment for localized osteosarcoma in patients
Collects data on patients with localized osteosarcoma treated under the 2021 Italian guidelines.
Plain-language title generated from the registry record
Registry title: Observational Study in Localized Osteosarcoma
Key facts
- Where
- Aviano, Bari, Bologna, Candiolo, Catania, Florence, Genova, Milan, Padova, Palermo, Pisa, Roma, and Trieste, ItalySee the 16 sites
Where in Italy
- Centro di Riferimento Oncologico - Unit of Medical OncologyAviano, ItalyTaking people
- Azienda Ospedaliero Universitaria Consorziale Policlinico - BariBari, ItalyTaking people
- A.O. Universitaria Policlinico S. Orsola Malpighi di BolognaBologna, ItalyTaking people
- IRCCS Istituto ortopedico RizzoliBologna, ItalyTaking people
- Sandra AlibertiCandiolo, ItalyTaking people
- AUO Policnico G. Rodolico San MarcoCatania, ItalyTaking people
- A.O. Universitaria MeyerFlorence, ItalyTaking people
- Istituto Giannina GasliniGenova, ItalyTaking people
- Fondazione IRCCS - Istituto Nazionale dei TumoriMilan, ItalyTaking people
- Fondazione IRCCS INT Milano SC Pediatria OncologicaMilan, ItalyTaking people
- Azienda Ospedaliera di Padova UOC Oncoematologia PediatricaPadova, ItalyTaking people
- ARNAS P. O. "Civico e Benfratelli"Palermo, ItalyTaking people
- Azienda Ospedaliero Universitaria PisanaPisa, ItalyTaking people
- Istituti Fisioterapici Ospitalieri di RomaRoma, ItalyTaking people
- Ospedale Pediatrico Bambin Gesu'Roma, ItalyNot yet recruiting
- IRCCS materno infantile Burlo GarofoloTrieste, ItalyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Italian Sarcoma Group
- Trial code
- NCT04890067
- Record updated
- 3 November 2026
- Original description
Observational prospective trial aimed to collect the collect demographic, clinical, surgical, pathological and molecular characteristics and treatment from patients affected by localized OsteoSarcoma (OS) treated according the AIEOP/Italian Sarcoma Group (ISG) OS 2021Read full original descriptionShow less
Multicenter Observational Study on the Treatment of Patients With Localized Osteosarcoma
Observational prospective trial aimed to collect the collect demographic, clinical, surgical, pathological and molecular characteristics and treatment from patients affected by localized OsteoSarcoma (OS) treated according the AIEOP/Italian Sarcoma Group (ISG) OS 2021
Inclusion: Diagnosis of high grade OS of the extremities; Age at diagnosis ≤ 40 years at the time of diagnosis; Localized disease (skip metastases are allowed); Adequate organ function according the AIEOP/ISG OS 2021 recommendation; Patients or parents oe guardians of minors who have given their written informed consent to participate in the study.
Exclusion: Any medical condition which can not allowed the use of the treatments recommended by AIEOP/ISG OS 2021; Presence of metastases; Diagnosis of periosteal OS, of parosteal OS or secondary OS.